The Role of <i>VEGFA, COX2, HUR </i>and <i>CUGBP2</i> in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients

The Role of <i>VEGFA, COX2, HUR </i>and <i>CUGBP2</i> in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients

<i>Background and objectives</i>: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore, the aim of this study was to i...

Full description

Bibliographic Details
Main Authors: Henrikas Pauzas, Ugne Gyvyte, Tadas Latkauskas, Laura Kairevice, Paulius Lizdenis, Saulius Svagzdys, Erika Birgiolaite, Irma Kuliaviene, Juozas Kupcinskas, Algimantas Tamelis
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Medicina
Subjects:
rectal cancer
neoadjuvant therapy
VEGFA
COX2
HUR
CUGBP2
Online Access:https://www.mdpi.com/1010-660X/56/4/192

Internet

https://www.mdpi.com/1010-660X/56/4/192

Similar Items